Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-13

Clinical Trial Update: Short Versus Long-term Levetiracetam in Brain Tumors [Phase 3]

View source ↗

Summary

Phase 3 trial comparing short-term versus long-term use of levetiracetam in patients with brain tumors and seizures; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Keppra (levetiracetam)

Snippet

Sponsor: Tata Memorial Centre | Conditions: Seizures, Brain Tumors | Phase 3 | Status: RECRUITING